Anxiolytic effects of acute and maintenance ketamine, as assessed by the Fear Questionnaire subscales and the Spielberger State Anxiety Rating Scale.

Truppman Lattie, Dylan; Nehoff, Hayley; Neehoff, Shona; Gray, Andrew; Glue, Paul

Truppman Lattie, Dylan; Nehoff, Hayley; Neehoff, Shona; Gray, Andrew; Glue, Paul.

Afiliación

Truppman Lattie D; Department of Psychological Medicine, University of Otago, Dunedin, New Zealand.
Nehoff H; Department of Psychological Medicine, University of Otago, Dunedin, New Zealand.
Neehoff S; Department of Psychological Medicine, University of Otago, Dunedin, New Zealand.
Gray A; Biostatistics Unit, Dean's Office, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.
Glue P; Department of Psychological Medicine, University of Otago, Dunedin, New Zealand.

J Psychopharmacol ; 35(2): 137-141, 2021 02.

Article en En | MEDLINE | ID: mdl-32900266

Asunto(s)

Ansiolíticos/uso terapéutico; Ansiedad/tratamiento farmacológico; Miedo/efectos de los fármacos; Ketamina/uso terapéutico; Trastornos de Ansiedad/tratamiento farmacológico; Método Doble Ciego; Femenino; Humanos; Masculino; Fobia Social/tratamiento farmacológico; Trastornos Fóbicos/tratamiento farmacológico; Psicometría/métodos; Encuestas y Cuestionarios

Palabras clave

Fear Questionnaire; Ketamine; Spielberger State Anxiety Inventory; anxiety; phobia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Ansiedad / Ansiolíticos / Miedo / Ketamina Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: J Psychopharmacol Asunto de la revista: PSICOFARMACOLOGIA Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google